CORNING HOSPITAL
1. Target Overview & Investment Thesis
CORNING HOSPITAL is a 65-bed suburban community hospital in STEUBEN, NY with $169.3M in net patient revenue and a 5.0% operating margin. The hospital serves a payer mix of 28.6% Medicare, 2.1% Medicaid, and 69.3% commercial.
Thesis: Turnaround. Our ML models identify $12.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 5.0% to 12.4% (+736bps).
| Net Revenue HCRIS | $169.3M |
| Current EBITDA COMPUTED | $8.5M |
| Operating Margin COMPUTED | 5.0% |
| Occupancy HCRIS | 73.3% |
| Revenue / Bed COMPUTED | $2.6M |
| Net-to-Gross HCRIS | 21.2% |
| Distress Probability ML | 39.3% |
2. Market Context & Competitive Position
NY has 196 Medicare-certified hospitals with a median operating margin of -17.5%. The target's margin of 5.0% places it above the state median. Among 46 size-comparable peers (32-130 beds), the median margin is -15.1%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (32-130), prioritizing same-state peers. 46 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CORNING HOSPITAL (Target) | NY | 65 | $169.3M | 5.0% |
| CAYUGA MEDICAL CENTER AT ITHAC | NY | 107 | $302.3M | -13.1% |
| PECONIC BAY MEDICAL CENTER | NY | 130 | $294.3M | -9.3% |
| NEW YORK PRESBYTERIAN HUDSON V | NY | 128 | $249.3M | -9.5% |
| CANTON-POTSDAM HOSPITAL | NY | 94 | $231.6M | -5.7% |
| EPISCOPAL HEALTH SERVICES | NY | 126 | $214.7M | -50.0% |
| ST. JOSEPHS MEDICAL CENTER | NY | 106 | $212.9M | -24.1% |
| FREDRICK FERRIS THOMPSON HOSPI | NY | 113 | $197.8M | -9.0% |
| NORTH CENTRAL BRONX | NY | 130 | $188.2M | -26.5% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $12.5M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $3.6M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $3.4M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $3.4M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $2.1M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $108K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $8.5M |
| + RCM Uplift | +$12.5M |
| Pro Forma EBITDA | $21.0M |
| Current Margin | 5.0% |
| Pro Forma Margin | 12.4% |
| WC Released (1x) | $6.5M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $13.1M | $180.9M | 13.79x | 69.0% |
| Base (11x exit) | 10.0x | 11.0x | $13.1M | $203.3M | 15.49x | 73.0% |
| Bull Case | 9.0x | 11.0x | $11.8M | $248.7M | 21.05x | 83.9% |
| Bull (12x exit) | 9.0x | 12.0x | $11.8M | $274.8M | 23.26x | 87.6% |
| Bear Case | 11.0x | 10.0x | $14.4M | $114.3M | 7.92x | 51.3% |
| Bear (11x exit) | 11.0x | 11.0x | $14.4M | $130.5M | 9.04x | 55.3% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 46 hospitals with 32-130 beds
- Same-state prioritization (n=47)
- Comp margins: P25=-27.3% / P50=-15.1% / P75=-9.4%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.